Literature DB >> 20331535

Top-up transfusions in neonates with Rh hemolytic disease in relation to exchange transfusions.

M E A Rath1, V E H J Smits-Wintjens, I Lindenburg, A Brand, D Oepkes, F J Walther, E Lopriore.   

Abstract

OBJECTIVE: To study the effect of a restrictive guideline for exchange transfusion (ET) on the number of top-up transfusions in neonates with Rh hemolytic disease. STUDY
DESIGN: Retrospective study of all (near)-term neonates with Rh hemolytic disease admitted to our center between 2000 and 2008. In December 2005, policy changed from using liberal ET criteria to more restrictive ET criteria. We recorded the number of ETs and the number of top-up transfusions in the group of neonates before (group I, n = 156) and after (group II, n = 27) the guideline change.
RESULTS: The percentage of neonates requiring an ET decreased from 66% (103/156) in group I to 26% (7/27) in group II (P < 0.01). The percentage of neonates receiving a top-up transfusion increased from 68% (105/154) in group I to 81% (22/27) in group II (P = 0.25). The median number of top-up transfusions increased from 1 (interquartile range 0-2) in group I to 2 (interquartile range 1-3) in group II (P = 0.01).
CONCLUSION: In this study, restrictive ET criteria in neonates with Rh hemolytic disease lead to a reduction of the rate of ET but an increase in the number of top-up transfusions for neonatal anemia.

Entities:  

Mesh:

Year:  2010        PMID: 20331535     DOI: 10.1111/j.1423-0410.2010.01307.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  5 in total

1.  Improving the management and outcome in haemolytic disease of the foetus and newborn.

Authors:  Enrico Lopriore; Mirjam E A Rath; Helen Liley; Vivianne E H J Smits-Wintjens
Journal:  Blood Transfus       Date:  2013-07-19       Impact factor: 3.443

2.  Neonatal outcomes of pregnancies affected by haemolytic disease of the foetus and newborn and managed with intrauterine transfusion: a service evaluation.

Authors:  Katherine A Birchenall; Sebastian E Illanes; Francisco Lopez; Timothy Overton; Rachel Liebling; Peter W Soothill; Sherif Abdel-Fattah; Mark Denbow
Journal:  Blood Transfus       Date:  2013-07-19       Impact factor: 3.443

3.  Exchange Transfusion for Severe Neonatal Hyperbilirubinemia: 17 Years' Experience from Vojvodina, Serbia.

Authors:  Nevenka Bujandric; Jasmina Grujic
Journal:  Indian J Hematol Blood Transfus       Date:  2015-04-02       Impact factor: 0.900

4.  Management of haemolytic disease of the foetus & newborn: steps to improve the outcomes.

Authors:  Sebastian E Illanes
Journal:  Indian J Med Res       Date:  2013       Impact factor: 2.375

Review 5.  Immunoglobulin for alloimmune hemolytic disease in neonates.

Authors:  Carolien Zwiers; Mirjam Ea Scheffer-Rath; Enrico Lopriore; Masja de Haas; Helen G Liley
Journal:  Cochrane Database Syst Rev       Date:  2018-03-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.